Cited 0 times in Scipus Cited Count

Real-World Effectiveness of Statin Therapy in Adult Asthma

DC Field Value Language
dc.contributor.authorPark, C-
dc.contributor.authorJang, JH-
dc.contributor.authorKim, C-
dc.contributor.authorLee, Y-
dc.contributor.authorLee, E-
dc.contributor.authorYang, HM-
dc.contributor.authorPark, RW-
dc.contributor.authorPark, HS-
dc.date.accessioned2024-03-14T04:52:28Z-
dc.date.available2024-03-14T04:52:28Z-
dc.date.issued2024-
dc.identifier.issn2213-2198-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32317-
dc.description.abstractBackground: Blood lipids affect airway inflammation in asthma. Although several studies have suggested anti-inflammatory effects of statins on asthmatic airways, further studies are needed to clarify the long-term effectiveness of statins on asthma control and whether they are an effective treatment option. Objective: To evaluate the long-term effectiveness of statins in the chronic management of adult asthma in real-world practice. Methods: Electronic medical record data spanning 28 years, collected from the Ajou University Medical Center in Korea, were used to conduct a retrospective study. Clinical outcomes were compared between patients with asthma who had maintained statin use (the statin group) and those not taking statins, whose blood lipid tests were always normal (the non-statin group). We performed propensity score matching and calculated hazard ratios with 95% CIs using the Cox proportional hazards model. Severe asthma exacerbation was the primary outcome; asthma exacerbation, asthma-related hospitalization, and new-onset type 2 diabetes mellitus and hypertension were secondary outcomes. Results: After 1:1 propensity score matching, the statin and non-statin groups each included 545 adult patients with asthma. The risk of severe asthma exacerbations and asthma exacerbations was significantly lower in the statin group than in the non-statin group (hazard ratios [95% CI] = 0.57 [0.35-0.90] and 0.71 [0.52-0.96], respectively). There were no significant differences in the risk of asthma-related hospitalization or new-onset type 2 diabetes mellitus or hypertension between groups (0.76 [0.53-1.09], 2.33 [0.94-6.59], and 1.71 [0.95-3.17], respectively). Conclusion: Statin use is associated with a lower risk of asthma exacerbation, with better clinical outcomes in adult asthma.-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAsthma-
dc.subject.MESHDiabetes Mellitus, Type 2-
dc.subject.MESHHumans-
dc.subject.MESHHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subject.MESHHypertension-
dc.subject.MESHRetrospective Studies-
dc.titleReal-World Effectiveness of Statin Therapy in Adult Asthma-
dc.typeArticle-
dc.identifier.pmid37866433-
dc.subject.keywordAdult-
dc.subject.keywordAsthma-
dc.subject.keywordDyslipidemia-
dc.subject.keywordStatin-
dc.contributor.affiliatedAuthorJang, JH-
dc.contributor.affiliatedAuthorLee, Y-
dc.contributor.affiliatedAuthorYang, HM-
dc.contributor.affiliatedAuthorPark, RW-
dc.contributor.affiliatedAuthorPark, HS-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.jaip.2023.10.029-
dc.citation.titleThe journal of allergy and clinical immunology. In practice-
dc.citation.volume12-
dc.citation.number2-
dc.citation.date2024-
dc.citation.startPage399-
dc.citation.endPage408.e1-e6-
dc.identifier.bibliographicCitationThe journal of allergy and clinical immunology. In practice, 12(2). : 399-408.e1-e6, 2024-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn2213-2201-
dc.relation.journalidJ022132198-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Journal Papers > School of Medicine / Graduate School of Medicine > Cardiology
Journal Papers > School of Medicine / Graduate School of Medicine > Biomedical Informatics
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse